碳离子放疗I期肺癌分次间误差摆位稳健性:骨匹配与肿瘤匹配对比
结果显示TM的V95%中位数100%优于BM的98.93%(p<0.001),TM所需外扩边距3.3 mm小于BM的7.9 mm。结论认为TM剂量分布更优,应使用容积成像替代二维X线片以实现TM。
要点
- TM的V95%中位数100%优于BM的98.93%(p<0.001)。
- TM所需外扩边距3.3 mm小于BM的7.9 mm。
- 实现TM需容积成像,应替代二维X线片用于I期肺癌碳离子放疗。
核心结论
- TM在I期非小细胞肺癌碳离子放疗中确保的剂量分布优于BM。
- 为实现TM,容积成像是关键,应替代二维X线片用于该人群碳离子治疗。
研究设计与样本
- 使用与治疗计划CT相同设置采集的确认CT(Conf-CT)评估两种摆位方法,并重新计算剂量分布。
主要发现
- BM与TM的V95%中位数分别为98.93%和100%(p<0.001)。
- BM与TM的正常肺V5Gy(RBE)均值分别为135.9和125.8(p=0.694)。
- BM与TM的估计所需外扩边距分别为7.9 mm和3.3 mm,较计划分别增加V5Gy(RBE)的53.9%和2.5%。
关键数值与推荐
- 评估指标包括临床靶区V95%、正常肺V5Gy(RBE)和接受率(V95%>95%的病例比例)。
- 所需外扩边距定义为在90%病例中达到可接受条件。
临床怎么用
- 对于I期肺癌碳离子放疗,应优先采用肿瘤匹配(TM)进行患者摆位以提高剂量覆盖。
- 应使用容积成像替代二维X线片,以支持肿瘤匹配的实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Patient positioning was compared by tumor matching (TM) and conventional bony structure matching (BM) in carbon ion radiotherapy for stage I non-small cell lung cancer to evaluate the robustness of TM and BM in determining interfractional error. MATERIAL AND METHODS: Sixty irradiation fields were analyzed. Computed tomography (CT) images acquired before treatment initiation for confirmation (Conf-CT) were obtained under the same settings as the treatment planning CT images and used to evaluate both positioning methods. The dose distributions were recalculated for Conf-CT using both BM and TM, and the dose-volume histogram parameters [V95% of clinical target volume, V5Gy(RBE) of normal lung, and acceptance ratio (ratio of cases with V95% > 95%)] were evaluated. The required margin, which in 90% of cases achieved the acceptable condition, was also examined. RESULTS: Using BM and TM, the median V95% was 98.93% and 100% (p < 0.001) and the mean V5Gy(RBE) was 135.9 and 125.8 (p = 0.694), respectively. The estimated required margins were 7.9 and 3.3 mm and increased by 53.9% and 2.5% of V5Gy(RBE), respectively, compared with planning. CONCLUSIONS: TM ensured a better dose distribution than did BM. To enable TM, volumetric imaging is crucial and should replace 2D radiographs for carbon therapy of stage I lung cancer.
引用
- Sakai M, Kubota Y, Saitoh JI, et al. Robustness of patient positioning for interfractional error in carbon ion radiotherapy for stage I lung cancer: Bone matching versus tumor matching. Radiother Oncol. 2018. PMID: 29100701. doi:10.1016/j.radonc.2017.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。